Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.81396408 |
2 | vocalization behavior (GO:0071625) | 4.35258245 |
3 | presynaptic membrane assembly (GO:0097105) | 4.29937914 |
4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.14521137 |
5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.14215350 |
6 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.13671353 |
7 | protein localization to synapse (GO:0035418) | 4.09767514 |
8 | synaptic vesicle exocytosis (GO:0016079) | 4.00951164 |
9 | neuronal action potential propagation (GO:0019227) | 3.86624306 |
10 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.81066415 |
11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.75687530 |
12 | neuron cell-cell adhesion (GO:0007158) | 3.74597542 |
13 | postsynaptic membrane organization (GO:0001941) | 3.73247360 |
14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.73089006 |
15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.71050493 |
16 | presynaptic membrane organization (GO:0097090) | 3.70916643 |
17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.69765140 |
18 | glutamate receptor signaling pathway (GO:0007215) | 3.62316023 |
19 | glutamate secretion (GO:0014047) | 3.61353884 |
20 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.44972130 |
21 | retinal cone cell development (GO:0046549) | 3.41737397 |
22 | synaptic transmission, glutamatergic (GO:0035249) | 3.40817103 |
23 | neuron-neuron synaptic transmission (GO:0007270) | 3.36941632 |
24 | regulation of synaptic vesicle transport (GO:1902803) | 3.36281321 |
25 | nerve growth factor signaling pathway (GO:0038180) | 3.34297319 |
26 | positive regulation of membrane potential (GO:0045838) | 3.33493661 |
27 | synaptic vesicle maturation (GO:0016188) | 3.31690994 |
28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.30363299 |
29 | * regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.29675811 |
30 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.26937975 |
31 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.26064000 |
32 | response to histamine (GO:0034776) | 3.25386569 |
33 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.25366185 |
34 | locomotory exploration behavior (GO:0035641) | 3.23250326 |
35 | startle response (GO:0001964) | 3.21364016 |
36 | * regulation of postsynaptic membrane potential (GO:0060078) | 3.16981100 |
37 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.14486704 |
38 | cellular response to ethanol (GO:0071361) | 3.10698423 |
39 | positive regulation of neurotransmitter transport (GO:0051590) | 3.10463799 |
40 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.09354254 |
41 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.06028246 |
42 | long-term synaptic potentiation (GO:0060291) | 3.03728847 |
43 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.03329324 |
44 | rhodopsin mediated signaling pathway (GO:0016056) | 3.00699234 |
45 | regulation of synapse structural plasticity (GO:0051823) | 2.99565035 |
46 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.97098498 |
47 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.96468121 |
48 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.96248388 |
49 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.93297792 |
50 | regulation of neurotransmitter secretion (GO:0046928) | 2.89550774 |
51 | long-term memory (GO:0007616) | 2.89333221 |
52 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.89113955 |
53 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.88755456 |
54 | negative regulation of cell killing (GO:0031342) | 2.88286048 |
55 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.88286048 |
56 | neurotransmitter secretion (GO:0007269) | 2.87575919 |
57 | response to interleukin-15 (GO:0070672) | 2.78140424 |
58 | detection of molecule of bacterial origin (GO:0032490) | 2.76982989 |
59 | cAMP catabolic process (GO:0006198) | 2.75127261 |
60 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.74319372 |
61 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.73088899 |
62 | negative regulation of dendrite development (GO:2000171) | 2.70587642 |
63 | detection of calcium ion (GO:0005513) | 2.70030533 |
64 | behavioral response to cocaine (GO:0048148) | 2.70029208 |
65 | exploration behavior (GO:0035640) | 2.67564010 |
66 | regulation of vesicle fusion (GO:0031338) | 2.66683020 |
67 | behavioral defense response (GO:0002209) | 2.66515274 |
68 | behavioral fear response (GO:0001662) | 2.66515274 |
69 | regulation of synaptic plasticity (GO:0048167) | 2.65784626 |
70 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.65489711 |
71 | striatum development (GO:0021756) | 2.65047072 |
72 | regulation of neurotransmitter transport (GO:0051588) | 2.63566437 |
73 | cellular response to interleukin-15 (GO:0071350) | 2.61892324 |
74 | membrane hyperpolarization (GO:0060081) | 2.60961900 |
75 | * membrane depolarization (GO:0051899) | 2.60953855 |
76 | cellular extravasation (GO:0045123) | 2.60346073 |
77 | regulation of cell communication by electrical coupling (GO:0010649) | 2.59304396 |
78 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.58538070 |
79 | detection of light stimulus involved in visual perception (GO:0050908) | 2.58538070 |
80 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.57984077 |
81 | eye photoreceptor cell development (GO:0042462) | 2.57865482 |
82 | photoreceptor cell development (GO:0042461) | 2.56472593 |
83 | negative regulation of interleukin-17 production (GO:0032700) | 2.56366036 |
84 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.55644810 |
85 | righting reflex (GO:0060013) | 2.54757378 |
86 | activated T cell proliferation (GO:0050798) | 2.54505448 |
87 | fear response (GO:0042596) | 2.54424827 |
88 | gamma-aminobutyric acid transport (GO:0015812) | 2.52599765 |
89 | innervation (GO:0060384) | 2.51891071 |
90 | female mating behavior (GO:0060180) | 2.51764768 |
91 | negative regulation of interleukin-12 production (GO:0032695) | 2.51472428 |
92 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.51435817 |
93 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.51259258 |
94 | regulation of female receptivity (GO:0045924) | 2.51189290 |
95 | synaptic vesicle endocytosis (GO:0048488) | 2.50023141 |
96 | regulation of gamma-delta T cell activation (GO:0046643) | 2.49878099 |
97 | germinal center formation (GO:0002467) | 2.48745917 |
98 | defense response to protozoan (GO:0042832) | 2.48292757 |
99 | membrane depolarization during action potential (GO:0086010) | 2.47261301 |
100 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.47224785 |
101 | macrophage activation involved in immune response (GO:0002281) | 2.47119318 |
102 | regulation of dendritic spine development (GO:0060998) | 2.46910748 |
103 | neurotransmitter transport (GO:0006836) | 2.46783771 |
104 | * learning (GO:0007612) | 2.46590747 |
105 | positive regulation of synaptic transmission (GO:0050806) | 2.46371922 |
106 | membrane assembly (GO:0071709) | 2.44614294 |
107 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.44296092 |
108 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.43126185 |
109 | Rap protein signal transduction (GO:0032486) | 2.42778620 |
110 | positive regulation of muscle hypertrophy (GO:0014742) | 2.42020497 |
111 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.42020497 |
112 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.42014731 |
113 | cyclic nucleotide catabolic process (GO:0009214) | 2.40507056 |
114 | synapse assembly (GO:0007416) | 2.40435741 |
115 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.37570914 |
116 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.37570914 |
117 | behavioral response to ethanol (GO:0048149) | 2.37254652 |
118 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.35728515 |
119 | synaptic transmission (GO:0007268) | 2.34960379 |
120 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.34069938 |
121 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.31856540 |
122 | photoreceptor cell maintenance (GO:0045494) | 2.31721624 |
123 | long term synaptic depression (GO:0060292) | 2.31240025 |
124 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.31050494 |
125 | cellular response to epinephrine stimulus (GO:0071872) | 2.26775731 |
126 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.23942273 |
127 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.23839336 |
128 | response to nerve growth factor (GO:1990089) | 2.23839336 |
129 | response to protozoan (GO:0001562) | 2.23821017 |
130 | macroautophagy (GO:0016236) | 2.23612125 |
131 | negative regulation of T cell mediated immunity (GO:0002710) | 2.23572493 |
132 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.22439284 |
133 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.21486875 |
134 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.16421211 |
135 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.13067960 |
136 | L-amino acid import (GO:0043092) | 2.11639664 |
137 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.11366812 |
138 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.11245683 |
139 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.10999317 |
140 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.10999317 |
141 | positive regulation of fibroblast migration (GO:0010763) | 2.10169270 |
142 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.07753182 |
143 | positive regulation by symbiont of host defense response (GO:0052509) | 2.07724957 |
144 | modulation by symbiont of host defense response (GO:0052031) | 2.07724957 |
145 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.07724957 |
146 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.07724957 |
147 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.07724957 |
148 | modulation by symbiont of host immune response (GO:0052553) | 2.07724957 |
149 | T-helper cell differentiation (GO:0042093) | 2.05622707 |
150 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.05622707 |
151 | interkinetic nuclear migration (GO:0022027) | 2.04704618 |
152 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.04438466 |
153 | detection of external biotic stimulus (GO:0098581) | 2.04350150 |
154 | macrophage activation (GO:0042116) | 2.04188514 |
155 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.03937918 |
156 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.03189825 |
157 | import into cell (GO:0098657) | 2.02811735 |
158 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.02301796 |
159 | positive regulation of Rap GTPase activity (GO:0032854) | 2.00615405 |
160 | negative T cell selection (GO:0043383) | 2.00031911 |
161 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.00001948 |
162 | regulation of ARF protein signal transduction (GO:0032012) | 1.98279419 |
163 | regulation of necroptotic process (GO:0060544) | 1.98047808 |
164 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 1.97903446 |
165 | necroptotic process (GO:0070266) | 1.96750986 |
166 | microglial cell activation (GO:0001774) | 1.96668572 |
167 | positive T cell selection (GO:0043368) | 1.96627495 |
168 | response to epinephrine (GO:0071871) | 1.95745063 |
169 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 1.95731352 |
170 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 1.95345072 |
171 | interferon-gamma-mediated signaling pathway (GO:0060333) | 1.95270700 |
172 | negative thymic T cell selection (GO:0045060) | 1.94297811 |
173 | negative regulation of neurotransmitter secretion (GO:0046929) | 1.93156895 |
174 | relaxation of cardiac muscle (GO:0055119) | 1.92761839 |
175 | interferon-gamma production (GO:0032609) | 1.92166850 |
176 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 1.91115463 |
177 | detection of other organism (GO:0098543) | 1.91021366 |
178 | leukocyte aggregation (GO:0070486) | 1.90912902 |
179 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 1.90740047 |
180 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 1.90251779 |
181 | regulation of macrophage cytokine production (GO:0010935) | 1.89476313 |
182 | negative regulation of adaptive immune response (GO:0002820) | 1.89108638 |
183 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.88511146 |
184 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 1.87107117 |
185 | regulation of alkaline phosphatase activity (GO:0010692) | 1.86928099 |
186 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 1.85669852 |
187 | B cell receptor signaling pathway (GO:0050853) | 1.85483894 |
188 | regulation of interleukin-17 production (GO:0032660) | 1.85365631 |
189 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 1.85339141 |
190 | regulation of relaxation of muscle (GO:1901077) | 1.84966193 |
191 | phospholipid translocation (GO:0045332) | 1.84755488 |
192 | lipid translocation (GO:0034204) | 1.84755488 |
193 | response to peptidoglycan (GO:0032494) | 1.84718150 |
194 | positive regulation of natural killer cell activation (GO:0032816) | 1.84345150 |
195 | myeloid dendritic cell differentiation (GO:0043011) | 1.83400008 |
196 | regulation of cardiac muscle hypertrophy (GO:0010611) | 1.83370080 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.48402120 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.95699935 |
3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.58255287 |
4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.57797725 |
5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.54011791 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.48166527 |
7 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.26872479 |
8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.26418766 |
9 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.25924434 |
10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.24578253 |
11 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.17136068 |
12 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.17136068 |
13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.14228971 |
14 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.12958919 |
15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.08732721 |
16 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.07864253 |
17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.06654813 |
18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.03078071 |
19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.01543293 |
20 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.99930073 |
21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98086419 |
22 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.96078459 |
23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.95842649 |
24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.94650624 |
25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.87173571 |
26 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.85444970 |
27 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.84984799 |
28 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.80536753 |
29 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.79889566 |
30 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.79168647 |
31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.77872536 |
32 | P300_19829295_ChIP-Seq_ESCs_Human | 1.76391539 |
33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.76159058 |
34 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.74595049 |
35 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.72657915 |
36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70757783 |
37 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.69172371 |
38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.68444832 |
39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.66140581 |
40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.65120027 |
41 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.63339469 |
42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.62348350 |
43 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59113611 |
44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.59031236 |
45 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.56473674 |
46 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.55300218 |
47 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54031766 |
48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.53226585 |
49 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.52779125 |
50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44538046 |
51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42959525 |
52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.41587728 |
53 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.40384892 |
54 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.40223746 |
55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.39980685 |
56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.37864918 |
57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.37702937 |
58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.37702937 |
59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36038107 |
60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35545596 |
61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35348748 |
62 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34923026 |
63 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.34146025 |
64 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33954803 |
65 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.33098893 |
66 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32713843 |
67 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32674588 |
68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31572426 |
69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31357631 |
70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.30678844 |
71 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.30143740 |
72 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29982570 |
73 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29850527 |
74 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.28605165 |
75 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.27948413 |
76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.27747001 |
77 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26675397 |
78 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.24835643 |
79 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24493928 |
80 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23945913 |
81 | TCF4_23295773_ChIP-Seq_U87_Human | 1.23291700 |
82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23012359 |
83 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22622856 |
84 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22319036 |
85 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.22039922 |
86 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.21312395 |
87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20930271 |
88 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.20438190 |
89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20425226 |
90 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20310444 |
91 | CJUN_26792858_Chip-Seq_BT549_Human | 1.20145744 |
92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19769118 |
93 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19024889 |
94 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18216316 |
95 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.18137939 |
96 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17545647 |
97 | VDR_22108803_ChIP-Seq_LS180_Human | 1.16999392 |
98 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16677256 |
99 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16596764 |
100 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16512812 |
101 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.16397441 |
102 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.16352489 |
103 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.16183712 |
104 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15783597 |
105 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.14985077 |
106 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14731471 |
107 | FUS_26573619_Chip-Seq_HEK293_Human | 1.14130374 |
108 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13311741 |
109 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12827611 |
110 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12441994 |
111 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12160892 |
112 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10480685 |
113 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10045527 |
114 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.09886783 |
115 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09425838 |
116 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08721753 |
117 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07972231 |
118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07940662 |
119 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06388508 |
120 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05998628 |
121 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.04925683 |
122 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.04355725 |
123 | * GATA1_22025678_ChIP-Seq_K562_Human | 1.04118012 |
124 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03285450 |
125 | * AR_19668381_ChIP-Seq_PC3_Human | 1.03095354 |
126 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02865795 |
127 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02725514 |
128 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.02112885 |
129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01301713 |
130 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.01087128 |
131 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00879484 |
132 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00766607 |
133 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98684277 |
134 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98025202 |
135 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97863979 |
136 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97663256 |
137 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.97348868 |
138 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96309286 |
139 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95887513 |
140 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91372958 |
141 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91361481 |
142 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90320786 |
143 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.89918761 |
144 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.89135007 |
145 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.88375458 |
146 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.84529031 |
147 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.83207660 |
148 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.81549465 |
149 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.81216308 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 4.67153168 |
2 | MP0003880_abnormal_central_pattern | 4.66389466 |
3 | * MP0003635_abnormal_synaptic_transmissio | 3.34667302 |
4 | MP0004270_analgesia | 3.07129100 |
5 | MP0009745_abnormal_behavioral_response | 3.06915531 |
6 | MP0003303_peritoneal_inflammation | 2.95550229 |
7 | MP0005551_abnormal_eye_electrophysiolog | 2.87129987 |
8 | MP0002822_catalepsy | 2.77772500 |
9 | MP0009046_muscle_twitch | 2.71826030 |
10 | * MP0002063_abnormal_learning/memory/cond | 2.69082304 |
11 | MP0001188_hyperpigmentation | 2.67104338 |
12 | MP0001968_abnormal_touch/_nociception | 2.65511232 |
13 | MP0002064_seizures | 2.62359459 |
14 | MP0003300_gastrointestinal_ulcer | 2.47651966 |
15 | MP0001486_abnormal_startle_reflex | 2.44125995 |
16 | * MP0002572_abnormal_emotion/affect_behav | 2.40159729 |
17 | MP0002272_abnormal_nervous_system | 2.24940437 |
18 | MP0001501_abnormal_sleep_pattern | 2.20870201 |
19 | MP0002734_abnormal_mechanical_nocicepti | 2.20767448 |
20 | MP0009780_abnormal_chondrocyte_physiolo | 2.20497205 |
21 | MP0005646_abnormal_pituitary_gland | 2.12347852 |
22 | MP0001790_abnormal_immune_system | 2.11959876 |
23 | MP0005387_immune_system_phenotype | 2.11959876 |
24 | MP0001984_abnormal_olfaction | 2.10920238 |
25 | MP0005671_abnormal_response_to | 2.04304844 |
26 | MP0001958_emphysema | 1.99394050 |
27 | MP0003172_abnormal_lysosome_physiology | 1.98682791 |
28 | MP0001835_abnormal_antigen_presentation | 1.97744334 |
29 | MP0002735_abnormal_chemical_nociception | 1.97367019 |
30 | MP0006082_CNS_inflammation | 1.94566239 |
31 | MP0003436_decreased_susceptibility_to | 1.92264621 |
32 | MP0003879_abnormal_hair_cell | 1.88611962 |
33 | MP0000685_abnormal_immune_system | 1.86201373 |
34 | MP0003690_abnormal_glial_cell | 1.84512592 |
35 | MP0003091_abnormal_cell_migration | 1.83238297 |
36 | MP0008569_lethality_at_weaning | 1.79984468 |
37 | * MP0002067_abnormal_sensory_capabilities | 1.79006255 |
38 | MP0005423_abnormal_somatic_nervous | 1.78977622 |
39 | MP0005000_abnormal_immune_tolerance | 1.78930200 |
40 | MP0005409_darkened_coat_color | 1.78504878 |
41 | MP0002736_abnormal_nociception_after | 1.74558308 |
42 | MP0002876_abnormal_thyroid_physiology | 1.70576757 |
43 | MP0002419_abnormal_innate_immunity | 1.68716642 |
44 | MP0001800_abnormal_humoral_immune | 1.68653476 |
45 | MP0002638_abnormal_pupillary_reflex | 1.65588902 |
46 | MP0002148_abnormal_hypersensitivity_rea | 1.64859966 |
47 | MP0001970_abnormal_pain_threshold | 1.58349478 |
48 | MP0001502_abnormal_circadian_rhythm | 1.56188598 |
49 | MP0003763_abnormal_thymus_physiology | 1.53441374 |
50 | MP0003828_pulmonary_edema | 1.52080922 |
51 | MP0009785_altered_susceptibility_to | 1.50155614 |
52 | MP0002998_abnormal_bone_remodeling | 1.49932429 |
53 | MP0002557_abnormal_social/conspecific_i | 1.48127261 |
54 | MP0002723_abnormal_immune_serum | 1.45481410 |
55 | MP0010386_abnormal_urinary_bladder | 1.44982210 |
56 | MP0006276_abnormal_autonomic_nervous | 1.44528157 |
57 | MP0000920_abnormal_myelination | 1.43284709 |
58 | MP0005025_abnormal_response_to | 1.42930751 |
59 | MP0000604_amyloidosis | 1.41294317 |
60 | MP0004883_abnormal_blood_vessel | 1.39745267 |
61 | MP0002452_abnormal_antigen_presenting | 1.39662506 |
62 | MP0004510_myositis | 1.39421783 |
63 | MP0005386_behavior/neurological_phenoty | 1.37575768 |
64 | MP0004924_abnormal_behavior | 1.37575768 |
65 | MP0002909_abnormal_adrenal_gland | 1.32967940 |
66 | MP0002733_abnormal_thermal_nociception | 1.32805150 |
67 | MP0002405_respiratory_system_inflammati | 1.32282652 |
68 | MP0001986_abnormal_taste_sensitivity | 1.31691880 |
69 | MP0004036_abnormal_muscle_relaxation | 1.31649861 |
70 | MP0001440_abnormal_grooming_behavior | 1.31514344 |
71 | MP0001533_abnormal_skeleton_physiology | 1.31488163 |
72 | MP0002184_abnormal_innervation | 1.30648347 |
73 | MP0005164_abnormal_response_to | 1.28954626 |
74 | MP0005253_abnormal_eye_physiology | 1.28564262 |
75 | MP0003191_abnormal_cellular_cholesterol | 1.26390319 |
76 | MP0002332_abnormal_exercise_endurance | 1.26074935 |
77 | MP0002420_abnormal_adaptive_immunity | 1.25711745 |
78 | MP0004145_abnormal_muscle_electrophysio | 1.24786448 |
79 | MP0005166_decreased_susceptibility_to | 1.24391036 |
80 | MP0001819_abnormal_immune_cell | 1.21543035 |
81 | MP0004130_abnormal_muscle_cell | 1.21127216 |
82 | MP0003279_aneurysm | 1.20970462 |
83 | MP0002166_altered_tumor_susceptibility | 1.17790836 |
84 | MP0004484_altered_response_of | 1.17620439 |
85 | MP0000751_myopathy | 1.16821561 |
86 | MP0004947_skin_inflammation | 1.13780454 |
87 | MP0005167_abnormal_blood-brain_barrier | 1.13427802 |
88 | MP0003950_abnormal_plasma_membrane | 1.12963833 |
89 | MP0003329_amyloid_beta_deposits | 1.12091196 |
90 | MP0008438_abnormal_cutaneous_collagen | 1.11793586 |
91 | MP0002009_preneoplasia | 1.11594254 |
92 | * MP0002882_abnormal_neuron_morphology | 1.10193010 |
93 | MP0002090_abnormal_vision | 1.09628364 |
94 | MP0003045_fibrosis | 1.08893790 |
95 | MP0002168_other_aberrant_phenotype | 1.08879513 |
96 | MP0000778_abnormal_nervous_system | 1.07591174 |
97 | MP0000015_abnormal_ear_pigmentation | 1.05359840 |
98 | MP0003656_abnormal_erythrocyte_physiolo | 1.05200266 |
99 | MP0001845_abnormal_inflammatory_respons | 1.05151978 |
100 | MP0003633_abnormal_nervous_system | 1.04545033 |
101 | MP0001851_eye_inflammation | 1.03943508 |
102 | MP0001873_stomach_inflammation | 1.03425278 |
103 | MP0003011_delayed_dark_adaptation | 1.02345243 |
104 | MP0000465_gastrointestinal_hemorrhage | 1.01857052 |
105 | MP0009840_abnormal_foam_cell | 1.01804802 |
106 | MP0004085_abnormal_heartbeat | 1.01077230 |
107 | MP0010155_abnormal_intestine_physiology | 1.01071017 |
108 | * MP0002229_neurodegeneration | 1.00432425 |
109 | MP0001177_atelectasis | 1.00081640 |
110 | MP0006072_abnormal_retinal_apoptosis | 1.00026283 |
111 | MP0002837_dystrophic_cardiac_calcinosis | 0.99975611 |
112 | MP0004811_abnormal_neuron_physiology | 0.99516083 |
113 | MP0003183_abnormal_peptide_metabolism | 0.97819524 |
114 | MP0003136_yellow_coat_color | 0.96072395 |
115 | MP0004142_abnormal_muscle_tone | 0.95451588 |
116 | MP0000371_diluted_coat_color | 0.94813910 |
117 | MP0005645_abnormal_hypothalamus_physiol | 0.93489063 |
118 | MP0005171_absent_coat_pigmentation | 0.93169062 |
119 | * MP0002066_abnormal_motor_capabilities/c | 0.93027945 |
120 | MP0001905_abnormal_dopamine_level | 0.92889003 |
121 | MP0002877_abnormal_melanocyte_morpholog | 0.91795183 |
122 | MP0000249_abnormal_blood_vessel | 0.91423294 |
123 | MP0004215_abnormal_myocardial_fiber | 0.90612368 |
124 | MP0003646_muscle_fatigue | 0.90287807 |
125 | MP0006292_abnormal_olfactory_placode | 0.90154968 |
126 | MP0004084_abnormal_cardiac_muscle | 0.89870771 |
127 | MP0003787_abnormal_imprinting | 0.89120271 |
128 | MP0003866_abnormal_defecation | 0.88344271 |
129 | MP0000767_abnormal_smooth_muscle | 0.88296890 |
130 | MP0008874_decreased_physiological_sensi | 0.86569172 |
131 | MP0001963_abnormal_hearing_physiology | 0.86053281 |
132 | MP0005275_abnormal_skin_tensile | 0.85524009 |
133 | MP0000716_abnormal_immune_system | 0.85154682 |
134 | MP0004381_abnormal_hair_follicle | 0.84776007 |
135 | MP0005084_abnormal_gallbladder_morpholo | 0.83608799 |
136 | MP0005195_abnormal_posterior_eye | 0.82810105 |
137 | MP0004742_abnormal_vestibular_system | 0.82734122 |
138 | MP0002138_abnormal_hepatobiliary_system | 0.82442003 |
139 | MP0002752_abnormal_somatic_nervous | 0.82068693 |
140 | MP0005595_abnormal_vascular_smooth | 0.81856959 |
141 | MP0008004_abnormal_stomach_pH | 0.81686198 |
142 | MP0002933_joint_inflammation | 0.81279207 |
143 | MP0000569_abnormal_digit_pigmentation | 0.79557272 |
144 | MP0005535_abnormal_body_temperature | 0.78699891 |
145 | MP0005058_abnormal_lysosome_morphology | 0.77117759 |
146 | MP0000343_altered_response_to | 0.76754361 |
147 | MP0002006_tumorigenesis | 0.76130506 |
148 | MP0001348_abnormal_lacrimal_gland | 0.75819894 |
149 | MP0002133_abnormal_respiratory_system | 0.75679832 |
150 | MP0005388_respiratory_system_phenotype | 0.75679832 |
151 | MP0006054_spinal_hemorrhage | 0.73992147 |
152 | MP0005464_abnormal_platelet_physiology | 0.72522883 |
153 | MP0000955_abnormal_spinal_cord | 0.71841211 |
154 | MP0003632_abnormal_nervous_system | 0.71253012 |
155 | MP0003634_abnormal_glial_cell | 0.71034511 |
156 | MP0005310_abnormal_salivary_gland | 0.69477077 |
157 | MP0005620_abnormal_muscle_contractility | 0.68721637 |
158 | MP0000013_abnormal_adipose_tissue | 0.68397125 |
159 | MP0003631_nervous_system_phenotype | 0.68130057 |
160 | MP0001324_abnormal_eye_pigmentation | 0.65002738 |
161 | MP0002069_abnormal_eating/drinking_beha | 0.63691468 |
162 | MP0000631_abnormal_neuroendocrine_gland | 0.63632468 |
163 | MP0009379_abnormal_foot_pigmentation | 0.62921901 |
164 | MP0000230_abnormal_systemic_arterial | 0.62895607 |
165 | MP0001664_abnormal_digestion | 0.61971917 |
166 | MP0003075_altered_response_to | 0.60693095 |
167 | MP0001765_abnormal_ion_homeostasis | 0.60508864 |
168 | MP0005174_abnormal_tail_pigmentation | 0.59779975 |
169 | MP0000026_abnormal_inner_ear | 0.59272046 |
170 | MP0005379_endocrine/exocrine_gland_phen | 0.56169864 |
171 | MP0003724_increased_susceptibility_to | 0.55349150 |
172 | MP0002972_abnormal_cardiac_muscle | 0.52724793 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.81810789 |
2 | Febrile seizures (HP:0002373) | 5.83240219 |
3 | Congenital stationary night blindness (HP:0007642) | 5.33480256 |
4 | Epileptic encephalopathy (HP:0200134) | 4.87619206 |
5 | Focal seizures (HP:0007359) | 4.46965601 |
6 | Atonic seizures (HP:0010819) | 4.44137703 |
7 | Hyperventilation (HP:0002883) | 4.02017946 |
8 | Myokymia (HP:0002411) | 3.88655687 |
9 | Broad-based gait (HP:0002136) | 3.59871770 |
10 | Dyschromatopsia (HP:0007641) | 3.55932391 |
11 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.55491318 |
12 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.54121497 |
13 | Absence seizures (HP:0002121) | 3.47975519 |
14 | Central scotoma (HP:0000603) | 3.45827514 |
15 | Abnormality of macular pigmentation (HP:0008002) | 3.43295893 |
16 | * Gaze-evoked nystagmus (HP:0000640) | 3.27814707 |
17 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.23367739 |
18 | Dialeptic seizures (HP:0011146) | 3.16652435 |
19 | Decreased central vision (HP:0007663) | 3.05167413 |
20 | Attenuation of retinal blood vessels (HP:0007843) | 2.98999139 |
21 | Spondylolisthesis (HP:0003302) | 2.98533444 |
22 | Visual hallucinations (HP:0002367) | 2.98002522 |
23 | * Progressive cerebellar ataxia (HP:0002073) | 2.96488406 |
24 | T lymphocytopenia (HP:0005403) | 2.95088940 |
25 | Eczematoid dermatitis (HP:0000976) | 2.91285993 |
26 | Generalized tonic-clonic seizures (HP:0002069) | 2.89374349 |
27 | Abnormality of T cell number (HP:0011839) | 2.82555069 |
28 | Action tremor (HP:0002345) | 2.70701903 |
29 | Recurrent bacterial skin infections (HP:0005406) | 2.69417514 |
30 | Pigmentary retinal degeneration (HP:0001146) | 2.66468817 |
31 | Orchitis (HP:0100796) | 2.61279585 |
32 | Abnormality of glycolipid metabolism (HP:0010969) | 2.61144706 |
33 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.61144706 |
34 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.61144706 |
35 | Blue irides (HP:0000635) | 2.58082995 |
36 | Gait imbalance (HP:0002141) | 2.57601079 |
37 | Medial flaring of the eyebrow (HP:0010747) | 2.57523244 |
38 | Generalized hypopigmentation of hair (HP:0011358) | 2.56682071 |
39 | Absent speech (HP:0001344) | 2.51372249 |
40 | Nonprogressive disorder (HP:0003680) | 2.48924925 |
41 | Abnormality of macrophages (HP:0004311) | 2.48811381 |
42 | Neurofibrillary tangles (HP:0002185) | 2.47312264 |
43 | Scotoma (HP:0000575) | 2.46076392 |
44 | Congenital primary aphakia (HP:0007707) | 2.45900589 |
45 | Fair hair (HP:0002286) | 2.44088779 |
46 | Prolonged QT interval (HP:0001657) | 2.42556580 |
47 | Pulmonary infiltrates (HP:0002113) | 2.38912364 |
48 | Drooling (HP:0002307) | 2.38266504 |
49 | Excessive salivation (HP:0003781) | 2.38266504 |
50 | Aortic dissection (HP:0002647) | 2.37127369 |
51 | Anxiety (HP:0000739) | 2.36741751 |
52 | Gastrointestinal infarctions (HP:0005244) | 2.36207701 |
53 | Severe visual impairment (HP:0001141) | 2.32330821 |
54 | Myositis (HP:0100614) | 2.31685629 |
55 | Nephrogenic diabetes insipidus (HP:0009806) | 2.31298094 |
56 | Protruding tongue (HP:0010808) | 2.28895686 |
57 | Submucous cleft hard palate (HP:0000176) | 2.28892941 |
58 | Inability to walk (HP:0002540) | 2.28867881 |
59 | Spontaneous hematomas (HP:0007420) | 2.28084568 |
60 | Increased corneal curvature (HP:0100692) | 2.27822621 |
61 | Keratoconus (HP:0000563) | 2.27822621 |
62 | Atrial fibrillation (HP:0005110) | 2.27645346 |
63 | Recurrent cutaneous fungal infections (HP:0011370) | 2.26884542 |
64 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.26884542 |
65 | Stomatitis (HP:0010280) | 2.26148209 |
66 | Papilledema (HP:0001085) | 2.22949567 |
67 | Mediastinal lymphadenopathy (HP:0100721) | 2.22181011 |
68 | Recurrent abscess formation (HP:0002722) | 2.21771668 |
69 | Aortic aneurysm (HP:0004942) | 2.20507204 |
70 | Abnormality of incisor morphology (HP:0011063) | 2.19354699 |
71 | Hyporeflexia of lower limbs (HP:0002600) | 2.18959088 |
72 | Choroideremia (HP:0001139) | 2.18433117 |
73 | Hemoptysis (HP:0002105) | 2.17736162 |
74 | Asymmetric septal hypertrophy (HP:0001670) | 2.17568986 |
75 | Progressive inability to walk (HP:0002505) | 2.17551852 |
76 | Recurrent fungal infections (HP:0002841) | 2.17138530 |
77 | Photophobia (HP:0000613) | 2.17071371 |
78 | Bradycardia (HP:0001662) | 2.16847325 |
79 | Cerebral inclusion bodies (HP:0100314) | 2.16271459 |
80 | Subacute progressive viral hepatitis (HP:0006572) | 2.15349871 |
81 | Vitreoretinal degeneration (HP:0000655) | 2.14959119 |
82 | Depression (HP:0000716) | 2.14817345 |
83 | Primary atrial arrhythmia (HP:0001692) | 2.14455155 |
84 | Increased CSF protein (HP:0002922) | 2.13106346 |
85 | Congenital sensorineural hearing impairment (HP:0008527) | 2.13099236 |
86 | Abnormal ciliary motility (HP:0012262) | 2.12988008 |
87 | Chorioretinal atrophy (HP:0000533) | 2.12613924 |
88 | Dysostosis multiplex (HP:0000943) | 2.11868205 |
89 | Bundle branch block (HP:0011710) | 2.11035334 |
90 | Arterial tortuosity (HP:0005116) | 2.10660124 |
91 | Peritonitis (HP:0002586) | 2.09817491 |
92 | Abnormal hair whorl (HP:0010721) | 2.09455209 |
93 | Syncope (HP:0001279) | 2.09030548 |
94 | Hemiplegia (HP:0002301) | 2.08317385 |
95 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.06633090 |
96 | Recurrent skin infections (HP:0001581) | 2.04818394 |
97 | Diplopia (HP:0000651) | 2.04789267 |
98 | Hematochezia (HP:0002573) | 2.03958511 |
99 | Absent frontal sinuses (HP:0002688) | 2.03154451 |
100 | Difficulty running (HP:0009046) | 2.01948882 |
101 | Abnormal eating behavior (HP:0100738) | 2.01523191 |
102 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01486827 |
103 | Mucopolysacchariduria (HP:0008155) | 2.01486827 |
104 | Stereotypic behavior (HP:0000733) | 2.00976041 |
105 | Widely spaced teeth (HP:0000687) | 2.00627577 |
106 | Gingivitis (HP:0000230) | 1.99904700 |
107 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99886421 |
108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99886421 |
109 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99886421 |
110 | Vascular tortuosity (HP:0004948) | 1.99799710 |
111 | Amblyopia (HP:0000646) | 1.98788247 |
112 | Hypothermia (HP:0002045) | 1.98513876 |
113 | Poor eye contact (HP:0000817) | 1.97884876 |
114 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.95493484 |
115 | Abnormal EKG (HP:0003115) | 1.95365106 |
116 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.93945386 |
117 | Supraventricular tachycardia (HP:0004755) | 1.93193907 |
118 | Postural instability (HP:0002172) | 1.93108872 |
119 | Optic neuritis (HP:0100653) | 1.92831452 |
120 | Retrobulbar optic neuritis (HP:0100654) | 1.92831452 |
121 | Poor coordination (HP:0002370) | 1.92483455 |
122 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.92333983 |
123 | Lower limb amyotrophy (HP:0007210) | 1.91561656 |
124 | * Truncal ataxia (HP:0002078) | 1.89745839 |
125 | Gingival bleeding (HP:0000225) | 1.89568297 |
126 | Retinitis pigmentosa (HP:0000510) | 1.89399733 |
127 | Autoimmune hemolytic anemia (HP:0001890) | 1.88718852 |
128 | Absent/shortened dynein arms (HP:0200106) | 1.88113041 |
129 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.88113041 |
130 | Chronic diarrhea (HP:0002028) | 1.87036375 |
131 | Chronic hepatic failure (HP:0100626) | 1.85601507 |
132 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.85522466 |
133 | Distal lower limb amyotrophy (HP:0008944) | 1.84344065 |
134 | Keratoconjunctivitis sicca (HP:0001097) | 1.83899724 |
135 | Supraventricular arrhythmia (HP:0005115) | 1.83838008 |
136 | True hermaphroditism (HP:0010459) | 1.82679880 |
137 | Abnormal social behavior (HP:0012433) | 1.82094215 |
138 | Impaired social interactions (HP:0000735) | 1.82094215 |
139 | Abnormality of salivation (HP:0100755) | 1.81700361 |
140 | Vasculitis (HP:0002633) | 1.81322167 |
141 | Overgrowth (HP:0001548) | 1.80367058 |
142 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.80204469 |
143 | Pulmonary embolism (HP:0002204) | 1.78111083 |
144 | Genital tract atresia (HP:0001827) | 1.77948238 |
145 | Type 1 muscle fiber predominance (HP:0003803) | 1.76582371 |
146 | Epileptiform EEG discharges (HP:0011182) | 1.76040569 |
147 | Deeply set eye (HP:0000490) | 1.75029044 |
148 | * Dysdiadochokinesis (HP:0002075) | 1.74176109 |
149 | Pancreatic fibrosis (HP:0100732) | 1.74114397 |
150 | * Dysmetria (HP:0001310) | 1.73471559 |
151 | Vaginal atresia (HP:0000148) | 1.72999814 |
152 | Supranuclear gaze palsy (HP:0000605) | 1.72835131 |
153 | Chest pain (HP:0100749) | 1.72196657 |
154 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.71995163 |
155 | Disinhibition (HP:0000734) | 1.71470133 |
156 | Abnormality of the nasal septum (HP:0000419) | 1.70876970 |
157 | Keratoconjunctivitis (HP:0001096) | 1.70711563 |
158 | Decreased circulating renin level (HP:0003351) | 1.70603973 |
159 | Increased cerebral lipofuscin (HP:0011813) | 1.70075303 |
160 | Agitation (HP:0000713) | 1.69804597 |
161 | Narrow palate (HP:0000189) | 1.69349780 |
162 | Spinal canal stenosis (HP:0003416) | 1.69004498 |
163 | Frequent falls (HP:0002359) | 1.68546155 |
164 | Thickened calvaria (HP:0002684) | 1.68418478 |
165 | Fetal akinesia sequence (HP:0001989) | 1.68209681 |
166 | Arterial thrombosis (HP:0004420) | 1.68156712 |
167 | Abnormality of the periventricular white matter (HP:0002518) | 1.67762400 |
168 | Obstructive sleep apnea (HP:0002870) | 1.67151899 |
169 | Muscle fiber splitting (HP:0003555) | 1.66687068 |
170 | Retinal dysplasia (HP:0007973) | 1.66655129 |
171 | Abnormality of binocular vision (HP:0011514) | 1.66652973 |
172 | Systemic lupus erythematosus (HP:0002725) | 1.66192993 |
173 | Autoimmune thrombocytopenia (HP:0001973) | 1.65125439 |
174 | Vacuolated lymphocytes (HP:0001922) | 1.65060283 |
175 | Cerebral aneurysm (HP:0004944) | 1.64194741 |
176 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.61942650 |
177 | Subaortic stenosis (HP:0001682) | 1.61942650 |
178 | Neuronal loss in central nervous system (HP:0002529) | 1.61588262 |
179 | Abnormality of the axillary hair (HP:0100134) | 1.59953362 |
180 | Abnormality of secondary sexual hair (HP:0009888) | 1.59953362 |
181 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.59576246 |
182 | Hypoplasia of the iris (HP:0007676) | 1.57657052 |
183 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.57362898 |
184 | Mutism (HP:0002300) | 1.57306683 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CASK | 4.70456200 |
2 | EPHA4 | 3.50641454 |
3 | MAP2K7 | 3.09038559 |
4 | NTRK3 | 3.00887561 |
5 | TRPM7 | 2.65359838 |
6 | INSRR | 2.47725390 |
7 | MAP3K12 | 2.46064302 |
8 | TNIK | 2.40978422 |
9 | MAP3K4 | 2.37094273 |
10 | MUSK | 2.29003596 |
11 | RIPK4 | 2.17088213 |
12 | SGK2 | 1.97013793 |
13 | AKT3 | 1.88243020 |
14 | DAPK2 | 1.87270120 |
15 | PRPF4B | 1.83508418 |
16 | BLK | 1.82416736 |
17 | CAMKK2 | 1.74814911 |
18 | TXK | 1.67978114 |
19 | BMPR2 | 1.66122107 |
20 | TYK2 | 1.50689916 |
21 | FES | 1.48410321 |
22 | PLK2 | 1.47702344 |
23 | MAP2K3 | 1.47476721 |
24 | MAP2K4 | 1.46592000 |
25 | SGK494 | 1.36200045 |
26 | SGK223 | 1.36200045 |
27 | NEK9 | 1.33159005 |
28 | SGK3 | 1.30893154 |
29 | PIK3CG | 1.30629998 |
30 | NLK | 1.29406145 |
31 | RIPK1 | 1.27843271 |
32 | MINK1 | 1.27497289 |
33 | CSK | 1.27210271 |
34 | NTRK2 | 1.26041404 |
35 | MAP3K3 | 1.23787960 |
36 | TNK2 | 1.23656182 |
37 | MAPK13 | 1.22306787 |
38 | STK38 | 1.19391984 |
39 | CAMK1 | 1.19082107 |
40 | TTN | 1.17143225 |
41 | SIK3 | 1.14849766 |
42 | DAPK1 | 1.13580915 |
43 | CAMKK1 | 1.12439665 |
44 | PINK1 | 1.12168109 |
45 | CDK19 | 1.11336399 |
46 | MATK | 1.08401782 |
47 | TGFBR2 | 1.07343012 |
48 | CAMK2A | 1.04575696 |
49 | PAK3 | 1.03411175 |
50 | PRKCH | 1.02208752 |
51 | PRKD2 | 1.00137641 |
52 | WNK1 | 0.97126644 |
53 | CDK5 | 0.96305516 |
54 | PDGFRB | 0.95784619 |
55 | MAP4K1 | 0.94990336 |
56 | FRK | 0.94419486 |
57 | CDC42BPA | 0.94274449 |
58 | SIK2 | 0.92768599 |
59 | ZAP70 | 0.91776421 |
60 | CDK3 | 0.91511481 |
61 | MAP3K13 | 0.90129293 |
62 | SGK1 | 0.89734926 |
63 | EPHB1 | 0.89646921 |
64 | MKNK2 | 0.89123990 |
65 | GRK1 | 0.88860583 |
66 | HCK | 0.88656777 |
67 | JAK2 | 0.88568708 |
68 | MAP3K9 | 0.87657055 |
69 | ITK | 0.86625173 |
70 | PRKCE | 0.86230258 |
71 | NEK6 | 0.86178043 |
72 | JAK3 | 0.85692133 |
73 | GRK5 | 0.85039249 |
74 | KIT | 0.84490387 |
75 | DDR2 | 0.78614760 |
76 | PRKCG | 0.78287150 |
77 | FGFR4 | 0.77641755 |
78 | MARK1 | 0.77051321 |
79 | PTK2B | 0.76869557 |
80 | PAK6 | 0.76819880 |
81 | SYK | 0.76784531 |
82 | EPHA3 | 0.75380564 |
83 | IRAK4 | 0.75189892 |
84 | MAP3K7 | 0.74764427 |
85 | MYLK | 0.74024593 |
86 | MAPK12 | 0.73254679 |
87 | PIK3CA | 0.72326659 |
88 | DMPK | 0.72271207 |
89 | PDPK1 | 0.71631335 |
90 | CAMK2B | 0.70930116 |
91 | IKBKB | 0.70339945 |
92 | NUAK1 | 0.69787473 |
93 | TYRO3 | 0.69194938 |
94 | RET | 0.68459300 |
95 | MAPK7 | 0.68290429 |
96 | MELK | 0.68240559 |
97 | JAK1 | 0.68118557 |
98 | NME1 | 0.67550851 |
99 | MARK2 | 0.67372242 |
100 | NTRK1 | 0.66575146 |
101 | CHUK | 0.66258875 |
102 | PHKG2 | 0.64612939 |
103 | PHKG1 | 0.64612939 |
104 | MAP3K14 | 0.63996909 |
105 | LCK | 0.62048684 |
106 | KSR1 | 0.61692925 |
107 | CAMK4 | 0.61057128 |
108 | STK11 | 0.60865149 |
109 | KSR2 | 0.60663340 |
110 | CAMK2D | 0.60642994 |
111 | DYRK1A | 0.60632351 |
112 | MAP3K1 | 0.59036856 |
113 | FGFR3 | 0.58004794 |
114 | TAOK1 | 0.57251522 |
115 | HIPK2 | 0.54490263 |
116 | PDGFRA | 0.54257386 |
117 | MARK3 | 0.52850691 |
118 | ZAK | 0.52565572 |
119 | CCNB1 | 0.51964170 |
120 | GRK7 | 0.51825578 |
121 | FER | 0.51813238 |
122 | TBK1 | 0.51813021 |
123 | ACVR1B | 0.50436669 |
124 | PRKD3 | 0.49729908 |
125 | PRKCQ | 0.48919675 |
126 | OBSCN | 0.48886022 |
127 | PRKAA2 | 0.48573231 |
128 | FYN | 0.48056343 |
129 | PRKG1 | 0.47263498 |
130 | CAMK1G | 0.46752682 |
131 | OXSR1 | 0.46384787 |
132 | TEC | 0.46209823 |
133 | ARAF | 0.43320252 |
134 | PDK1 | 0.43037114 |
135 | MAP3K2 | 0.42743977 |
136 | IKBKE | 0.42517518 |
137 | STK24 | 0.42072088 |
138 | MAP3K6 | 0.39131712 |
139 | * PRKACA | 0.38629353 |
140 | TAOK3 | 0.38603674 |
141 | MAP3K5 | 0.38503332 |
142 | ADRBK1 | 0.35147557 |
143 | IRAK1 | 0.35004120 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phototransduction_Homo sapiens_hsa04744 | 3.79865107 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.35343836 |
3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.64106595 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.49542029 |
5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.47693806 |
6 | Morphine addiction_Homo sapiens_hsa05032 | 2.44404809 |
7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.40081528 |
8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.29603242 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.25422867 |
10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.14253819 |
11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.02879694 |
12 | Salivary secretion_Homo sapiens_hsa04970 | 1.90717169 |
13 | Insulin secretion_Homo sapiens_hsa04911 | 1.82757923 |
14 | Taste transduction_Homo sapiens_hsa04742 | 1.79886844 |
15 | Renin secretion_Homo sapiens_hsa04924 | 1.73444871 |
16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.72861784 |
17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.68686790 |
18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67115757 |
19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.64670083 |
20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.58395076 |
21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.51975452 |
22 | Long-term depression_Homo sapiens_hsa04730 | 1.45854287 |
23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.42722456 |
24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.41751793 |
25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37626179 |
26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.35906964 |
27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.35741061 |
28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.35683232 |
29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.34130383 |
30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.32688747 |
31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32165103 |
32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.30963614 |
33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25599473 |
34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.22453352 |
35 | Malaria_Homo sapiens_hsa05144 | 1.20757181 |
36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16639155 |
37 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.16344573 |
38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.15458301 |
39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.14463713 |
40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.13993301 |
41 | Measles_Homo sapiens_hsa05162 | 1.13920749 |
42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11099304 |
43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10656371 |
44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10465356 |
45 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08428171 |
46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.07779466 |
47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06607778 |
48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06170101 |
49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04297999 |
50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.03916865 |
51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00388313 |
52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99839728 |
53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98666560 |
54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94873908 |
55 | Amoebiasis_Homo sapiens_hsa05146 | 0.93398680 |
56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92952484 |
57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91544847 |
58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91014954 |
59 | Pertussis_Homo sapiens_hsa05133 | 0.90311093 |
60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89412206 |
61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88365556 |
62 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.86905556 |
63 | Influenza A_Homo sapiens_hsa05164 | 0.85774094 |
64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85473873 |
65 | Insulin resistance_Homo sapiens_hsa04931 | 0.84101566 |
66 | Melanogenesis_Homo sapiens_hsa04916 | 0.83348591 |
67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83145408 |
68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82550902 |
69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81677448 |
70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.81655821 |
71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.81523544 |
72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81053124 |
73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80310311 |
74 | Gap junction_Homo sapiens_hsa04540 | 0.80228523 |
75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78169983 |
76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77463332 |
77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77197382 |
78 | Legionellosis_Homo sapiens_hsa05134 | 0.75511116 |
79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75181739 |
80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.75132922 |
81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74947368 |
82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.74624689 |
83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74553864 |
84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74333750 |
85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72876745 |
86 | Lysosome_Homo sapiens_hsa04142 | 0.72820508 |
87 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.72720452 |
88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.72238095 |
89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70838939 |
90 | Hepatitis C_Homo sapiens_hsa05160 | 0.70489897 |
91 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.70230052 |
92 | Focal adhesion_Homo sapiens_hsa04510 | 0.69384471 |
93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69303198 |
94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68848289 |
95 | Hepatitis B_Homo sapiens_hsa05161 | 0.68477835 |
96 | Glioma_Homo sapiens_hsa05214 | 0.68252773 |
97 | Allograft rejection_Homo sapiens_hsa05330 | 0.67559585 |
98 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67417888 |
99 | Axon guidance_Homo sapiens_hsa04360 | 0.67129884 |
100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66801377 |
101 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66703445 |
102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66343246 |
103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65010591 |
104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64196137 |
105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63487324 |
106 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63297922 |
107 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63166888 |
108 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63034550 |
109 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62484293 |
110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62168155 |
111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61962230 |
112 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59787905 |
113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58093655 |
114 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56814266 |
115 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55799259 |
116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55268418 |
117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54560870 |
118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53834089 |
119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51646299 |
120 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51079882 |
121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48708553 |
122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46645744 |
123 | Asthma_Homo sapiens_hsa05310 | 0.46575464 |
124 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46519544 |
125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45216325 |
126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44719094 |
127 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44572483 |
128 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44359551 |
129 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43472093 |
130 | Platelet activation_Homo sapiens_hsa04611 | 0.42377836 |
131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41064606 |
132 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40431041 |
133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38789238 |
134 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.38140895 |
135 | Tuberculosis_Homo sapiens_hsa05152 | 0.33070224 |
136 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.32746449 |
137 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32156405 |
138 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.31879062 |
139 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.29939857 |
140 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.29307406 |
141 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.29229993 |